Landos Biopharma, Inc.
USD22.93
+0.13 (+0.57%)
CEO
Gregory Oakes
IPO Date
2021-02-04
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$22.93
Prev. Close
$22.80
Day Low
$22.75
Day High
$22.94
52W Low
$3.15
52W High
$22.94
Market Cap
$0.07B
Volume
0.05M
| -0.5 |
| 31 Dec 2021 | FY | 98.9% | -212.4% | -50.1% | -41.2% | 0.00 | 5.55 | -5.1 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | 55.8% | -99.4% | 0.00 | 2.71 | -16.0 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | 54.5% | -27.6% | 0.00 | 16.56 | -34.5 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -604.4% | -216.2% | 0.00 | 1.39 | -79.6 |
| -0.9 |
| 30 Sept 2023 | Q3 | 0.0% | 0.0% | -15.6% | -13.6% | 0.00 | 7.77 | -1.0 |
| 30 Jun 2023 | Q2 | 0.0% | 0.0% | -9.1% | -8.5% | 0.00 | 15.35 | -1.7 |
| 31 Mar 2023 | Q1 | 0.0% | 0.0% | -11.9% | -10.9% | 0.00 | 12.30 | -0.9 |
| 31 Dec 2022 | Q4 | 0.0% | 0.0% | -9.9% | -8.6% | 0.00 | 7.39 | -1.3 |
| 30 Sept 2022 | Q3 | 0.0% | 0.0% | -18.1% | -16.1% | 0.00 | 9.04 | -0.8 |
| 30 Jun 2022 | Q2 | 0.0% | 0.0% | -21.9% | -19.5% | 0.00 | 8.92 | -0.6 |
| 31 Mar 2022 | Q1 | 0.0% | 0.0% | -23.8% | -19.0% | 0.00 | 4.99 | -1.0 |
| 31 Dec 2021 | Q4 | 100.0% | 111.7% | -26.4% | -21.6% | 0.00 | 5.55 | -2.4 |